OPINION
NEWS
REGIONS
WORLD
BUSINESS
SPORTS
ENTERTAINMENT
LIFESTYLE
THE SUNDAY TIMES
SPECIAL FEATURES
SPECIAL SECTIONS
TMT NEWSWIRE
FAST TIMES
LEGAL ADVICE
CAMPUS PRESS
VIDEOS
EXPATS & DIPLOMATS
PHOTOS
BUSINESS FORUM
PODCASTS
RESOURCES
WEATHER
MARKET OVERVIEW
CLASSIFIEDS
EXAM RESULTS
TMT DIGITAL EDITION
TMT CSI
TMT 126TH ANNIVERSARY
QUIZZES
GAMES
Sign In
New user?
Click Here
OPINION
NEWS
REGIONS
WORLD
BUSINESS
SPORTS
ENTERTAINMENT
LIFESTYLE
THE SUNDAY TIMES
SPECIAL FEATURES
SPECIAL SECTIONS
TMT NEWSWIRE
FAST TIMES
LEGAL ADVICE
CAMPUS PRESS
VIDEOS
EXPATS & DIPLOMATS
PHOTOS
BUSINESS FORUM
PODCASTS
RESOURCES
WEATHER
MARKET OVERVIEW
CLASSIFIEDS
EXAM RESULTS
TMT DIGITAL EDITION
TMT CSI
TMT 126TH ANNIVERSARY
QUIZZES
GAMES
TMT Newswire
>
GlobeNewswire
Renown Health Welcomes First Kidney Transplant Surgeon & Chief of Transplant Surgery Program
by GlobeNewswire
Oct 11, 2024 2:59 am
NEXT ARTICLE
Related Articles
Questex's Fierce Electronics and Sensors Converge Launch the Inaugural Fierce Electronics 40 Under 40 Program Honoring the Next Generation of Trailblazers in Electronics Innovation
Mullen Receives Expected Nasdaq Notice Regarding Delayed Form 10-K
Aurora Spine Announces Leadership Promotions: Matt Paxton, Executive Vice President of Sales and Katelyn Sims, Area Vice President of Commercialization and Key Accounts
CVB Financial Corp. Reports Earnings for the Fourth Quarter and the Year Ended 2024
Data Published Today in the New England Journal of Medicine Demonstrates Anthos Therapeutics' novel Factor XI inhibitor, Abelacimab 150mg, Reduced Major or Clinically Relevant Non-Major Bleeding by 62% Compared to Rivaroxaban (Xarelto) in Patients with Atrial Fibrillation
Brown & Brown, Inc. announces quarterly cash dividend
Interparfums, Inc. Reports Record 2024 Fourth Quarter and Full Year Net Sales